The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies. A randomized, single-blind, placebo-control trial.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Zonisamide (Primary)
- Indications Lewy body disease
- Focus Therapeutic Use
- 08 Jun 2017 Results of post hoc analysis assessing effects of zonisamide on cognition and BPSD, presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 05 Aug 2016 Status changed from recruiting to completed.
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.